{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:11:36Z","timestamp":1771081896164,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["080883\/E\/06\/D"],"award-info":[{"award-number":["080883\/E\/06\/D"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Introduction<\/jats:title><jats:p>Quality of medicines in both developed and developing countries is sometimes compromised due to infiltration of counterfeit, substandard or degraded medicines into the markets. It is a public health concern as poor quality medicines endanger public health where patients are exposed to chemical toxins and\/or sub-therapeutic doses. This could lead to reduced treatment efficacy and promote development of drug resistance. Co-trimoxazole, a fixed dose combination of sulfamethoxazole and trimethoprim, is a broad spectrum for bacterial diseases and is also used as a prophylaxis for opportunistic infections in HIV infected individuals. This study evaluated quality of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>A total of 106 samples were collected, categorized into 15 brands and evaluated for active pharmaceutical ingredient content (API) and pH following United States Pharmacopeia. Assay for API was conducted using High Performance Liquid Chromatography. Results were compared with pharmacopeia references. Visual examination of labels and confirmation of retention status of the brands with Pharmacy and Poisons Board retention register was carried out.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>The samples were primarily of local origin (86.7%). On October 23, 2019, retention status of six of the fifteen brands documented were no longer listed in the Pharmacy and Poisons Board retention register. Of the 106 samples tested 70.6% and 86.8% were compliant with United States Pharmacopeia (USP) specifications for pH and API respectively while 84.0% adhered to packaging and labelling requirements.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>This study has demonstrated that majority of co-trimoxazole suspensions tested were compliant with USP requirements. Additionally, it has provided evidence of poor quality co-trimoxazole medicines that could compromise treatment of infectious diseases in children. This emphasizes the need for regular quality assurance tests to ensure only quality medicines are in the market.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0257625","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T17:44:43Z","timestamp":1632332683000},"page":"e0257625","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9966-0572","authenticated-orcid":true,"given":"Beatrice Njeri","family":"Irungu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian C.","family":"Koech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce M.","family":"Ondicho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia K.","family":"Keter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"issue":"4","key":"pone.0257625.ref001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3126\/jcmc.v6i4.16721","article-title":"The state of the world\u2019s antibiotics 2015","volume":"6","author":"PR Shankar","year":"2017","journal-title":"Journal of Chitwan Medical College"},{"issue":"01","key":"pone.0257625.ref002","first-page":"1","article-title":"Global Spread of Antibiotic Resistance Renders Current Antibiotics Infective","volume":"2019","author":"R Nassiri","year":"2019","journal-title":"Pharmacology: Drug Action Study journal"},{"key":"pone.0257625.ref003","unstructured":"Organization WH. WHO report on surveillance of antibiotic consumption: 2016\u20132018 early implementation. 2018;"},{"issue":"2","key":"pone.0257625.ref004","first-page":"38","article-title":"In-vitro evaluation of the quality of Paracetamol and Co-trimoxazole tablets used in Malawi based on pharmacopoeial standards","volume":"26","author":"F Khuluza","year":"2014","journal-title":"Malawi Medical Journal"},{"key":"pone.0257625.ref005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/IDR.S234684","article-title":"Physicochemical Quality Assessment of Antimalarial Medicines: Chloroquine Phosphate and Quinine Sulfate Tablets from Drug Retail Outlets of South-West Ethiopia","volume":"13","author":"H Abuye","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0257625.ref006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12936-019-3045-y","article-title":"Usefulness of combined screening methods for rapid detection of falsified and\/or substandard medicines in the absence of a confirmatory method","volume":"18","author":"KF-M Opuni","year":"2019","journal-title":"Malar J"},{"issue":"9","key":"pone.0257625.ref007","doi-asserted-by":"crossref","first-page":"e0184165","DOI":"10.1371\/journal.pone.0184165","article-title":"Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab","volume":"12","author":"Dif\u00e4m-EPN Minilab Survey Group","year":"2017","journal-title":"PLoS ONE"},{"issue":"5","key":"pone.0257625.ref008","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4269\/ajtmh.19-0247","article-title":"A Cross-Sectional Investigation of the Quality of Selected Medicines for Noncommunicable Diseases in Private Community Drug Outlets in Cambodia during 2011\u20132013","volume":"101","author":"MS Rahman","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pone.0257625.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-15-13","article-title":"A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010","volume":"15","author":"N Yoshida","year":"2014","journal-title":"BMC Pharmacology and Toxicology"},{"key":"pone.0257625.ref010","doi-asserted-by":"crossref","first-page":"110143","DOI":"10.1016\/j.forsciint.2020.110143","article-title":"Falsified tadalafil tablets distributed in Japan via the internet","volume":"307","author":"T Sanada","year":"2020","journal-title":"Forensic Sci Int"},{"issue":"5","key":"pone.0257625.ref011","doi-asserted-by":"crossref","first-page":"e96810","DOI":"10.1371\/journal.pone.0096810","article-title":"Quality of Antimalarial Drugs and Antibiotics in Papua New Guinea: A Survey of the Health Facility Supply Chain","volume":"9","author":"MW Hetzel","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"pone.0257625.ref012","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2334-10-203","article-title":"Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia","volume":"10","author":"U Hadi","year":"2010","journal-title":"BMC infectious diseases"},{"issue":"1","key":"pone.0257625.ref013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-3156.2006.01769.x","article-title":"Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo","volume":"12","author":"MA Atemnkeng","year":"2007","journal-title":"Tropical Medicine & International Health"},{"issue":"6","key":"pone.0257625.ref014","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2710.2005.00685.x","article-title":"The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector","volume":"30","author":"AA Amin","year":"2005","journal-title":"Journal of clinical pharmacy and therapeutics"},{"issue":"1","key":"pone.0257625.ref015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12936-018-2482-3","article-title":"The quality of anti-malarial medicines in Embu County, Kenya","volume":"17","author":"S Ndwigah","year":"2018","journal-title":"Malar J"},{"key":"pone.0257625.ref016","article-title":"Quality Performance of Drugs Analyzed in the Drug Analysis and Research Unit (DARU) during the Period 2006\u20132010","author":"K Abuga","year":"2013","journal-title":"East and Central African Journal of Pharmaceutical Sciences"},{"issue":"1","key":"pone.0257625.ref017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40801-016-0100-7","article-title":"Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients","volume":"4","author":"F Wafula","year":"2017","journal-title":"Drugs Real World Outcomes"},{"issue":"3","key":"pone.0257625.ref018","doi-asserted-by":"crossref","DOI":"10.4314\/ecajps.v11i3.46286","article-title":"Drug quality control in Kenya: Observation in the drug analysis and research unit during the period 2001\u20132005","volume":"11","author":"GN Thoithi","year":"2008","journal-title":"East and Central African Journal of Pharmaceutical Sciences"},{"key":"pone.0257625.ref019","unstructured":"Minyeto D. In vitro comparative evaluation of the quality and pharmaceutical equivalence of selected generic ciprofloxacin hydrochloride tablet brands marketed in Kenya [Internet]. University of Narobi; 2014 [cited 2015 Feb 23]. http:\/\/erepository.uonbi.ac.ke\/handle\/11295\/76456"},{"key":"pone.0257625.ref020","first-page":"14","article-title":"Quality of the Antibiotics\u2014Amoxicillin and Co-Trimoxazole from Ghana, Nigeria, and the United Kingdom","author":"I Fadeyi","year":"2015","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pone.0257625.ref021","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7091278","article-title":"Quality and Brands of Amoxicillin Formulations in Nairobi, Kenya","volume":"2020","author":"LC Koech","year":"2020","journal-title":"BioMed Research International"},{"issue":"1","key":"pone.0257625.ref022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-0691.2011.03613.x","article-title":"Contemporary unconventional clinical use of co-trimoxazole","volume":"18","author":"E Goldberg","year":"2012","journal-title":"Clinical Microbiology and Infection"},{"issue":"486","key":"pone.0257625.ref023","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav0537","article-title":"Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation","volume":"11","author":"CD Bourke","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"pone.0257625.ref024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/22221751.2019.1588078","article-title":"Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV\/AIDS patients receiving antiretroviral therapy: a retrospective cohort study","volume":"8","author":"J Jiang","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"pone.0257625.ref025","first-page":"2018","article-title":"Quality Assessment of Some Essential Children\u2019s Medicines Sold in Licensed Outlets in Ashanti Region, Ghana","author":"G Frimpong","year":"2018","journal-title":"Journal of tropical medicine"},{"issue":"11","key":"pone.0257625.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165785","article-title":"The quality of selected essential medicines sold in accredited drug dispensing outlets and pharmacies in Tanzania","volume":"11","author":"E Kaale","year":"2016","journal-title":"PloS one"},{"key":"pone.0257625.ref027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-137-54647-0_3","volume-title":"Making Medicines in Africa","author":"R Simonetti","year":"2016"},{"issue":"1","key":"pone.0257625.ref028","first-page":"1","article-title":"prices and availability of locally produced and imported medicines in kenya","volume":"4","author":"M Ewen","year":"2018","journal-title":"Health Action International"},{"key":"pone.0257625.ref029","unstructured":"Kenya National Bureau of Statistics. Kenya Population and Housing Census Reports\u2014Kenya National Bureau of Statistics [Internet]. Kenya National Bureau of Statistics. 2019 [cited 2020 Mar 30]. https:\/\/www.knbs.or.ke\/?p=5732"},{"key":"pone.0257625.ref030","unstructured":"World Bank Group. Decision Meeeting Draft:Republic of Kenya Country Social Analysis. Nairobi; 2006."},{"key":"pone.0257625.ref031","unstructured":"World Bank Group. Kenya Economic Update: Policy Options to Advance the Big 4. Nairobi, Kenya; 2018."},{"key":"pone.0257625.ref032","unstructured":"Morgan D, Krejcie R. Sample Size Determination Using Krejcie and Morgan Table. Kenya Projects Organization (KENPRO). 1970;"},{"issue":"2","key":"pone.0257625.ref033","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/15598608.2017.1353456","article-title":"Recent developments in systematic sampling: a review","volume":"12","author":"A Sayed","year":"2018","journal-title":"Journal of Statistical Theory and Practice"},{"key":"pone.0257625.ref034","unstructured":"USP 40\u2013NF 35. United States Pharmacopoeia 40\u2013National Formulary 35. 2017. 4061\u20134062 p."},{"key":"pone.0257625.ref035","unstructured":"World Health Organization. Annex 9 Guidelines on packaging for pharmaceutical. WHO Technical Report Series. 2002."},{"key":"pone.0257625.ref036","unstructured":"Orwa J, Keter L, Ouko S. PA, Rukunga GM, Kibwage IO. Quality of some Pharmaceutical Products Manufactured in Kenya.\". 2008. 2008;"},{"key":"pone.0257625.ref037","unstructured":"Pharmacy and Poisons Board. Registration of Drugs\u2014Guidelines to Submission of Applications. Kenya, 2010 [Internet]. 2010 [cited 2020 Mar 18]. p. 1\u201394. https:\/\/apps.who.int\/medicinedocs\/en\/m\/abstract\/Js21380en\/"},{"issue":"5","key":"pone.0257625.ref038","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/S2214-109X(17)30147-X","article-title":"Co-trimoxazole for HIV-exposed uninfected infants","volume":"5","author":"C Evans","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"1","key":"pone.0257625.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0637-z","article-title":"Post-marketing surveillance of anti-malarial medicines used in Malawi","volume":"14","author":"I Chikowe","year":"2015","journal-title":"Malaria journal"},{"issue":"3","key":"pone.0257625.ref040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4269\/ajtmh.17-0732","article-title":"The quality of medicines used in children and supplied by private pharmaceutical wholesalers in Kinshasa, Democratic Republic of Congo: a prospective survey","volume":"98","author":"B Schiavetti","year":"2018","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"6","key":"pone.0257625.ref041","doi-asserted-by":"crossref","first-page":"6","DOI":"10.22270\/ajprd.v7i6.615","article-title":"Quality Assessment of Antibiotic Oral Drug Formulations Marketed In Katsina State, Nigeria","volume":"7","author":"MG Lawal","year":"2019","journal-title":"Asian Journal of Pharmaceutical Research and Development"},{"issue":"2","key":"pone.0257625.ref042","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bcp.12298","article-title":"Substandard drugs: a potential crisis for public health","volume":"78","author":"A Johnston","year":"2014","journal-title":"British journal of clinical pharmacology"},{"key":"pone.0257625.ref043","unstructured":"WHO. WHO | Guidelines on the implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce [Internet]. World Health Organization. World Health Organization; 2015 [cited 2020 Apr 26]. https:\/\/www.who.int\/medicines\/areas\/quality_safety\/regulation_legislation\/certification\/guidelines\/en\/index6.html"},{"issue":"12","key":"pone.0257625.ref044","doi-asserted-by":"crossref","first-page":"e1717","DOI":"10.1016\/S2214-109X(19)30422-X","article-title":"Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial","volume":"7","author":"B Daniels","year":"2019","journal-title":"The Lancet Global Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T06:05:19Z","timestamp":1699509919000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257625"}},"subtitle":[],"editor":[{"given":"Richard","family":"Mankin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0257625","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}